Skip to main content

Table 4 Mean difference and standard error between the SLT and placebo treatments for each EEG band and ERP component (all μV)

From: The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial

  Mean Difference ± Standard Error
EEG Spectral Band Eyes Open Eyes Closed
 Delta -1.64 ± -0.01 -0.07 ± -0.73
 Theta -0.82 ± -0.37 0.20 ± -0.32
 Alpha -0.16 ± 0.44 -3.66 ± -0.94
 Beta 2.14 ± 0.82 -0.65 ± -0.5
Visual ERP Component Target Nontarget
 N1 -1.72 ± -0.06 -0.45 ± -0.17
 P2 -0.37 ± -0.08 -0.69 ± 0.02
 N2 -0.74 ± -0.06 -0.05 ± -0.26
 P3a 2.58 ± 0.02 1.98 ± -0.20
 P3b -1.12 ± 0.10 -1.38 ± -0.04
Auditory ERP Component Target Nontarget
N1 2.14 ± 0.11 -1.38 ± -0.14
 P2 1.16 ± 0.84 -1.02 ± -0.31
 N2 -0.14 ± 1.78 -0.04 ± -0.13
P3a 3.65 ± 0.07 -0.36 ± -0.08
 P3b 0.58 ± -0.25 -2.27 ± 0.10
  1. Note: The bolded ERP components had a treatment × time × stimulus type interaction (p < .10)
\